Sage Journals: Discover world-class research

Retricted access

Research article

First published 2015-4

LCZ696 (Angiotensin–Neprilysin Inhibition)

Antony Q. Pham, Yesha Patel, Brittany Gallagher

Journal of Pharmacy Practice

Free access

Research article

First published 2019-9

AHU377+Valsartan (LCZ696) Modulates Renin–Angiotensin System (RAS) in the Cardiac of Female Spontaneously Hypertensive Rats Compared With Valsartan

Yang Zhao, Ruixin Ma, Xiaorong Yu [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Research article

First published 2019-9

LCZ696,an angiotensin receptor-neprilysin inhibitor,ameliorates diabetic cardiomyopathy by inhibiting inflammation,oxidative stress and apoptosis

Qing Ge, Li Zhao, Xiao-Min Ren [...]

Experimental Biology and Medicine

Retricted access

Case report

First published 2016-11

Early improvement of symptoms using LCZ696 in a patient with systolic heart failure and a reduced ejection fraction: a case report

Johannes Kohlmeier, Peter Bramlage

Perfusion

Free access

Research article

First published 2017-9

The Effects of LCZ696 in Patients With Hypertension Compared With Angiotensin Receptor Blockers

Yang Zhao, Heng Yu, Xu Zhao [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Free access

Review article

First published 2016-11

Sacubitril/valsartan in heart failure: latest evidence and place in therapy

Edgardo Kaplinsky

Sage Open Chronic Disease

Retricted access

Research article

First published 2016-2

Emerging Therapies for Acute and Chronic Heart Failure

Sarah Hanigan, Robert J. DiDomenico

Journal of Pharmacy Practice

Retricted access

Review article

First published 2016-6

A New Mechanism of Action in Heart Failure

Jonathan Richardson, Tosin David, Yasmin Grace [...]

Journal of Pharmacy Technology

Free access

Review article

First published 2018-8

Sacubitril/valsartan in cardiovascular disease: evidence to date and place in therapy

Srikanth Yandrapalli, Mohammed Hasan Khan, Yogita Rochlani [...]

Therapeutic Advances in Cardiovascular Disease

Open access

Research article

First published 2024

Comparison of the Efficacy and Safety of Sacubitril/Valsartan and Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients With Reduced Ejection Fraction Combined With Moderate-to-Severe Chronic Kidney Disease

Zhaowei Zhang, Shenjue Chen, Xuchun Xu [...]

Journal of Cardiovascular Pharmacology and Therapeutics

Search results